Prime Minister Narendra Modi launched the vaccination drive with healthcare workers at the front-line of India's COVID-19 battle getting their first jabs on January 16.
India’s drug regulator has approved two vaccines - Covaxin developed by Bharat Biotech and Covishield from the Oxford/AstraZeneca stable being manufactured by the Serum Institute of India (SII) - for emergency use in the country.
Follow our LIVE blog for the latest updates of the novel coronavirus pandemic
According to the government, the shots will be offered first to an estimated one crore healthcare workers and around two crore frontline workers, and then to persons above 50 years of age, followed by persons younger than 50 years of age with associated comorbidities.
India, one of the world's biggest drugmakers, has been approached by numerous countries for its anti-coronavirus doses.
The country has delivered two million vaccine doses to Bangladesh under the grants assistance programme on January 21. The country sent 1,50,000 doses of Covishield vaccines to Bhutan, 1,00,000 doses to the Maldives on January 20 and 1 million doses of Covishield vaccine to Nepal, to which Nepal Prime Minister KP Oli has thanked the Indian government.
Follow our full coverage on COVID-19 here.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
